Ramucirumab plus atezolizumab in patients with stage IV non-small cell lung cancer previously treated with immune checkpoint inhibitors
| Autor: | Herzog, Brett H., Waqar, Saiama N., Devarakonda, Siddhartha, Ward, Jeffrey P., Gao, Feng, Govindan, Ramaswamy, Morgensztern, Daniel |
|---|---|
| Zdroj: | In Lung Cancer November 2022 173:101-106 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect